EU Commission opens antitrust probe into Sanofi's flu vaccine campaign

The European Commission has initiated an antitrust investigation into Sanofi's flu vaccine marketing tactics, probing whether the pharmaceutical giant violated competition rules. This move comes amid concerns that Sanofi may have engaged in unfair practices to promote its flu vaccines over competitors. Such investigations are crucial as they aim to ensure fair market competition and protect consumers from monopolistic behavior, which could lead to higher prices and limited vaccine choices. The outcome could have significant implications for both Sanofi and the broader pharmaceutical industry.